• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[On the molecular drug design from viewpoint of precision medicine].

作者信息

Guo Zong-ru

出版信息

Yao Xue Xue Bao. 2017 Jan;52(1):71-9.

PMID:29911773
Abstract

Precision medicine (PM) involves the application of "omics" analysis and system biology to analyze the cause of disease at the molecular level for targeted treatments of individual patient. Based on the targeted treatment PM is closely related to pharmaceuticals, which, as a therapeutic means and supply front, mainly embody the two aspects: drug discovery/development, and clinical administration. Innovation of new molecular entities with safety and specific efficacy is the prerequisite and guarantee for the PM practice; on the other hand, the outcome and clues in clinical PM feedback to new drug research. PM and drug research/application are interdependent and promote each other. Aimed at precision medicine, drug discovery and development involve well-known contents: the discovery and validation of targets, the association between target functions and indications (proof of concept), lead discovery and optimization, the association between preclinical investigations and clinical trials, the lean of industrialization and pharmacoeconomics. At the molecular level the therapeutic efficacy originates from the interactive binding between specific atoms or groups of the drug molecule and the complementary atoms or groups of the macromolecular target in three-dimensional space. The strict arrangement of such critical atoms, groups, or fragments reflect specific features for a precise binding to the corresponding target. An alteration of amino acid residues in mutational targets leads to the change in conformation of the target protein, and an accurate structure of drug is necessary for binding to the mutant species and avoiding off-targeting effect. For the tailoring of clinical treatment to the individual patient design and development of various new molecular entities are critical for treatment choice according to the molecular features of biological markers of patients. This article provides some examples and methods of drug design and development in the new period.

摘要

相似文献

1
[On the molecular drug design from viewpoint of precision medicine].
Yao Xue Xue Bao. 2017 Jan;52(1):71-9.
2
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].[药物分子设计策略:分子宏观性质与微观结构的统一]
Yao Xue Xue Bao. 2008 Mar;43(3):227-33.
3
Translational medicine--a paradigm shift in modern drug discovery and development: the role of biomarkers.转化医学——现代药物发现和开发的范式转变:生物标志物的作用。
Adv Exp Med Biol. 2009;655:1-12. doi: 10.1007/978-1-4419-1132-2_1.
4
[Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].[精准医学:在特定情况下向前迈出的一大步,在难治性癌症中是神话吗?]
Bull Cancer. 2018 Apr;105(4):375-396. doi: 10.1016/j.bulcan.2018.01.009. Epub 2018 Mar 1.
5
Personalized medicine and economic evaluation in oncology: all theory and no practice?肿瘤学中的个性化医疗与经济评估:全是理论而无实践?
Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):733-8. doi: 10.1586/14737167.2015.1078239. Epub 2015 Aug 9.
6
Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.通过设计改进候选药物:关注物理化学性质,以改善化合物处置和安全性。
Chem Res Toxicol. 2011 Sep 19;24(9):1420-56. doi: 10.1021/tx200211v. Epub 2011 Jul 26.
7
[Strategy of molecular drug design: hits, leads and drug candidates].[分子药物设计策略:活性分子、先导化合物和候选药物]
Yao Xue Xue Bao. 2008 Sep;43(9):898-904.
8
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
9
Five critical elements to ensure the precision medicine.确保精准医疗的五个关键要素。
Cancer Metastasis Rev. 2015 Jun;34(2):313-8. doi: 10.1007/s10555-015-9555-3.
10
The principle of safety evaluation in medicinal drug - how can toxicology contribute to drug discovery and development as a multidisciplinary science?药物安全性评价的原则——毒理学作为一门多学科科学如何为药物研发做出贡献?
J Toxicol Sci. 2016;41(Special):SP49-SP67. doi: 10.2131/jts.41.SP49.